ALLMedicine™ Urticaria Center

Jun 14th, 2021 - The basophil activation test (BAT) is a complementary in vitro diagnostic test that can be used in addition to clinical history, skin test (ST), and specific IgE (sIgE) determination in the evaluation of IgE-mediated allergic reactions to food, in...

Jun 14th, 2021 - Bilastine is a second-generation H1 antihistamine indicated for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria. On the basis of the demonstrated efficacy and safety of the oral formulation, a new ophthalmic formulation of ...

Jun 13th, 2021 - Eosinophilic annular erythema is an idiopathic acute eosinophilic dermatosis. It is a rare condition, with approximately 30 cases reported in the English literature. It features annular, figurate urticarial edematous plaques primarily affecting th...

Jun 8th, 2021 - Urticaria is an acute or chronic inflammatory dermatosis that is characterized by erythematous, edematous, itchy, and transient urticarial plaques that cover the skin and mucous membranes. The aim of this study was to evaluate the knowledge of con...

Jun 8th, 2021 - Characteristics of patients with chronic spontaneous urticaria showing early and complete responses to omalizumab.|2021|Cho YT,Fu KT,Yang CW,Chu CY,|

Apr 9th, 2021 - The Moderna mRNA-1273 vaccine was authorized by the Food and Drug Administration for emergency use during the ongoing COVID-19 pandemic in December 2020.1 Out of 15,185 participants in the phase III Coronavirus Efficacy (COVE) trials who received ...

May 13th, 2020 - Cutaneous manifestations, a well-known effect of viral infections, are beginning to be reported in patients with COVID-19 disease. These manifestations most often are morbilliform rash, urticaria, vesicular eruptions, acral lesions, and livedoid e...

Jan 17th, 2018 - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. I...

Feb 25th, 2015 - This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well ...

Jun 5th, 2014 - This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured con...

Jun 14th, 2021 - The basophil activation test (BAT) is a complementary in vitro diagnostic test that can be used in addition to clinical history, skin test (ST), and specific IgE (sIgE) determination in the evaluation of IgE-mediated allergic reactions to food, in...

Jun 14th, 2021 - Bilastine is a second-generation H1 antihistamine indicated for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria. On the basis of the demonstrated efficacy and safety of the oral formulation, a new ophthalmic formulation of ...

Jun 14th, 2021 - For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and ...

Jun 14th, 2021 - Levocetirizine dihydrochloride is a histamine H1-receptor antagonist indicated for: •The treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria (1.2) Levocetirizine dihydrochloride tablets are indicated for the treatmen...

Jun 13th, 2021 - Eosinophilic annular erythema is an idiopathic acute eosinophilic dermatosis. It is a rare condition, with approximately 30 cases reported in the English literature. It features annular, figurate urticarial edematous plaques primarily affecting th...

Apr 9th, 2021 - The Moderna mRNA-1273 vaccine was authorized by the Food and Drug Administration for emergency use during the ongoing COVID-19 pandemic in December 2020.1 Out of 15,185 participants in the phase III Coronavirus Efficacy (COVE) trials who received ...

Sep 29th, 2020 - NEW YORK (Reuters Health) - Pressure urticaria in an infant can be misdiagnosed as physical abuse, according to a case report. "While physicians and healthcare providers should be keen on screening for mistreatment, different presentations of skin...

Sep 7th, 2020 - Although anaphylaxis can occur without skin symptoms, cutaneous reactions are the most common clinical manifestations of an allergic reaction to a food or food additive. Peanuts remain the most common cause of severe food allergy symptoms and anap...

Jun 14th, 2020 - Answer 5/5 Which of the following treatment options is recommended for patients with severe CSU? Your peers chose: Combination antihistamine agents 0% Increasing the antihistamine dose 0% Switching to a different antihistamine 0% Prescribing a "co...

Jun 14th, 2020 - Both the American Academy of Allergy, Asthma, and Immunology (AAAAI) and the European Academy of Allergy and Clinical Immunology (EAACI)/Global Allergy and Asthma European Network (GA2LEN)/European Dermatology Forum (EDF)/World Allergy Organizatio...